Apr 11 |
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
|
Apr 9 |
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
|
Jan 16 |
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
|
Dec 6 |
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
|
Nov 9 |
OncoCyte Corporation (OCX) Q3 2023 Earnings Call Transcript
|
Nov 9 |
OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon
|
Nov 9 |
OncoCyte GAAP EPS of -$0.81 beats by $0.20, revenue of $0.43M beats by $0.12M
|
Nov 9 |
Oncocyte Reports Third Quarter 2023 Financial Results
|
Nov 8 |
OncoCyte Q3 2023 Earnings Preview
|
Nov 3 |
Oncocyte to Announce Third Quarter 2023 Financial Results
|